Recent advances in pediatric colorectal cancer: a systematic review
- Navdeep Dhoat 1, Shilpa Sharma 2,3
- Navdeep Dhoat 1, Shilpa Sharma 2,3
- 1Department of Pediatric Surgery, All India Institute of Medical Sciences, Bhatinda, India. drndhoat@gmail.com.
- 2Professor, Department of Pediatric Surgery, Mother and Child Block, All India Institute of Medical Sciences, New Delhi, India. drshilpas@gmail.com.
- 3Department of Hepatobiliary Surgery and Liver Transplantation, Institute of Liver and Biliary Sciences, New Delhi, India. drshilpas@gmail.com.
- 0Department of Pediatric Surgery, All India Institute of Medical Sciences, Bhatinda, India. drndhoat@gmail.com.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Pediatric colorectal cancer (PCRC) exhibits unique molecular profiles, differing from adult CRC, particularly in WNT and PI3K-AKT pathways. These findings emphasize the need for tailored, age-specific treatments and precision medicine approaches for improved PCRC outcomes.
Area Of Science
- Oncology
- Genetics
- Pediatric Medicine
Background
- Pediatric colorectal cancer (PCRC) is a rare but distinct entity.
- Understanding its unique characteristics is crucial for effective management.
Purpose Of The Study
- To review recent advances in pediatric colorectal cancer (PCRC).
- Focus on molecular profiling, clinical and genetic features, screening, and treatment strategies.
Main Methods
- A comprehensive PubMed search was conducted for pediatric colorectal cancer articles published in the last year.
- 10 relevant articles focusing on molecular profiles or screening guidelines in pediatric cases were selected, detailing 38 tumors in 36 patients.
Main Results
- PCRC presents with symptoms like abdominal pain, distension, vomiting, and obstruction.
- Distinct genomic landscapes were observed compared to adult CRC, with differences in WNT and PI3K-AKT pathways.
- Higher RNF43 mutations and CDK6 amplification were noted in PCRC, alongside potential mismatch repair deficiency.
Conclusions
- Unique molecular signatures in PCRC necessitate age-specific treatment strategies.
- Multidisciplinary care and precision medicine are vital for improving PCRC outcomes.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

